• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

CIDRAP - WHO adds new recommendation for COVID-19 monoclonal antibody combo

Shiloh

Editor, Senior Moderator
Source: https://www.cidrap.umn.edu/news-per...mmendation-covid-19-monoclonal-antibody-combo


WHO adds new recommendation for COVID-19 monoclonal antibody combo
Filed Under:
COVID-19
Lisa Schnirring | News Editor | CIDRAP News
| Sep 24, 2021


In a statement, the WHO said it welcomed the new treatment recommendation, but raised concerns about the high price and limited production, as well as safe and appropriate handling of the medicine.
It said UNITAID, a global health group, is negotiating with Roche to make the drug for a lower price and for equitable distribution to include lower- and middle-income countries. The WHO said it is also in talks with the company about donations that would be distributed through UNICEF.
Also, the WHO warned of possible challenges in rolling out the new antibody treatment, typically given by IV. In outpatient settings, injection administration at the lowest dose may be an option.
To support equitable treatment, the WHO suggested reserving doses for those known to benefit most from it: those without severe illness who are at high hospitalization risk and those with severe illness who don't have antibodies, based on assessment with rapid tests.

More global headlines

South Korea today is expected to report record-high cases, as people return from autumn harvest travel, Yonhap News It notes that about 75% of cases are from the Seoul area. Officials eased gathering restrictions a bit over the holidays, but tightened them again today.
  • The nongovernmental health organization Oxfam said this week that Yemen is battling a third surge of COVID-19 activity, with cases recently tripling and deaths rising more than fivefold. It added that less than 1% of the country's population has received one vaccine dose and that COVAX has delivered only 511,000 of the promised 4.2 million doses. More than 4 million people have been displaced due to conflict, resulting in a humanitarian crisis that, along with COVID-19, further weakens Yemen's fragile health system.
  • The global total today rose to 230,912,407 cases, and 4,733,562 people have died from their infections, according to the Johns Hopkins tracker.
 
Back
Top Bottom